Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Hydroxyurea chemotherapy in the treatment of meningiomas.

Hydroxyurea chemotherapy in the treatment of meningiomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Hydroxyurea chemotherapy in the treatment of meningiomas. Abstract Text:

    herbert b newtonHerbert B Newton,herbert b newtonHerbert B Newton,

    Meningiomas are slow growing, extraaxial tumors that derive from the arachnoidal cap cells of the meninges. Resection remains the main modality of treatment and can be curative in some cases. External-beam radiotherapy and radiosurgery can benefit selected patients. The role of chemotherapy continues to be defined, but should be considered for patients with inoperable or frequently recurring meningiomas. Hydroxyurea, an inhibitor of ribonucleotide reductase, is one of the most active agents and is known to induce apoptosis in meningioma cells in vitro and in mouse xenografts. Results of preliminary clinical studies suggest that hydroxyurea has modest activity against recurrent and inoperable meningiomas, and can induce long term stabilization in some patients. However, the results are conflicting and a few clinical trials did not show positive results. Further clinical trials with larger patient cohorts and longer follow-up periods will be necessary to confirm the activity of hydroxyurea.

    Hydroxyurea chemotherapy in the treatment of meningiomas. Publishing Authors By Initials

    hb newtonHB Newton,hb newtonHB Newton,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Hydroxyurea chemotherapy in the treatment of meningiomas. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Neurosurgical focus

    VOLUME: 23

    Page Numbers: E11

    Journal Abbreviation:

    ISSN: 1092-0684

    DAY: 26

    MONTH: 10

    YEAR: 2007

    Hydroxyurea chemotherapy in the treatment of meningiomas. Information

    Number of References: 65

    LANGUAGE: eng

    NlmUniqueID: 100896471

    Hydroxyurea chemotherapy in the treatment of meningiomas. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Hydroxyurea chemotherapy in the treatment of meningiomas. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Hydroxyurea chemotherapy in the treatment of meningiomas.

    AFFILIATION: Dardinger Neuro-Oncology Center and Division of Neuro-Oncology, Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio 43210, USA. newton.2@osu.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Neurosurg Focus

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Hydroxyurea chemotherapy in the treatment of meningiomas Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News